WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
The WHO has prequalified the multi-dose vial presentation of the maternal respiratory syncytial virus (RSV) vaccine, RSVpreF (ABRYSVO®).
News
Partner Organisations
Consensus Statement: NCDs and Immunisation – Advancing Coordinated Advocacy and Action
Provides a shared foundation for advancing adult immunisation as an important component of healthier ageing, NCD prevention, management, and care.
News
Partner Organisations
The FIP Montreal Declaration on Non-Communicable Diseases (NCDs)
A call to recognise pharmacists as essential primary healthcare providers in strengthening prevention and management of non-communicable diseases.
European Parliament adopts recommendations in response to EU Safe Hearts Plan
545 MEPs voted in favour of recommendations to tackle key risk factors and ensure early detection, improved care, preparedness & response.
News
Reports
Partner Organisations
EHMA: Prepact - A Receptivity Assessment for HMPV and RSV Diagnosis in Older Adults
EMA White Paper assessing receptivity to improving testing and surveillance for RSV & HMPV across Europe, with a specific focus on older adults.
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
(Recording available) ESWI Partner Session at WOHC2026 - The Ongoing H5N1 Panzootic: A Continuing Threat to Animals and Humans
Now available to watch On Demand - ESWI session at 9th World One Health Congress in Lisbon, 6 September 2026.
Protective effect of A(H5N8) stockpiled vaccine against a virus genetically identical to a human isolate of bovine A(H5N1) influenza virus
This finding highlights the vaccine's potential utility during the early phase of an emerging pandemic threat.
